Skip to main content

Advertisement

Table 1 Model parameters

From: Cost effectiveness of recombinant factor VIIa for treatment of intracerebral hemorrhage

  Probabilities
Variable No RX rFVIIa (40 mcg) rFVIIa (80 mcg) Utilities Range
Mild post-ICH deficit (mRS 0–1) 0. 08 0. 17 0. 21 0. 81 0. 70–0. 95
Moderate post-ICH deficit (mRS 2–3) 0. 23 0. 29 0. 29 0. 55 0. 2–0. 65
Severe post-ICH deficit (mRS 4–5) 0. 40 0. 37 0. 30 0. 25 (-0. 2)-0. 45
Death after ICH 0. 29 0. 18 0. 18 0 0
Arterial thromboembolic event   0. 02 0. 02 0. 55  
Probability of dying after ATE   0. 29 0. 29